Drug Type Small molecule drug |
Synonyms BSC 2201, BSC2201 |
Target |
Action inhibitors |
Mechanism ALK5 inhibitors(Transforming growth factor beta receptor 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | Discovery | South Korea | 01 Jul 2026 | |
| Neoplasms | Discovery | South Korea | 09 May 2023 |





